-
-
-
-
-
-
-
AMGEN TO PRESENT AT JEFFERIES GLOBAL HEALTHCARE CONFERENCE
-
-
-
-
-
-
-
Amgen investors await weight-loss drug data
-
-
-
-
-
-
-
US FTC sues to block Amgen's $27.8 billion deal for Horizon Therapeutics
-
-
-
-
-
-
-
Amgen's (AMGN) CodeBreak200 Has Some Risk From Docetaxel - Jefferies
-
-
-
-
-
-
-
Amgen posts higher third-quarter sales, but trims full-year estimate
-
-
-
-
-
-
-
Amgen (AMGN) PT Raised to $235 at Jefferies
-
-
-
-
-
-
-
Amgen (AMGN): Reasons Neulasta May Not Be Approved - Jefferies
-
73,257 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

